人类对强毒力福氏志贺菌2a的反应。 - Suppr

Suppr

超能文献

The response of man to virulent Shigella flexneri 2a.

作者信息

DuPont H L, Hornick R B, Dawkins A T, Snyder M J, Formal S B

出版信息

J Infect Dis. 1969 Mar;119(3):296-9. doi: 10.1093/infdis/119.3.296.

DOI:10.1093/infdis/119.3.296

PMID:5780532

Abstract

摘要

相似文献

The response of man to virulent Shigella flexneri 2a.

J Infect Dis. 1969 Mar;119(3):296-9. doi: 10.1093/infdis/119.3.296.

[Research on active immunity of man in bacillary dysentery. 3. Maintenance of the non-pathogenic character of the Shigella flexneri 2a TXXXII strain orally administered to volunteers].

Arch Roum Pathol Exp Microbiol. 1965 Sep;24(3):677-86.

Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.

J Infect Dis. 1991 Sep;164(3):533-7. doi: 10.1093/infdis/164.3.533.

Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.

Vaccine. 2017 Sep 5;35(37):4990-4996. doi: 10.1016/j.vaccine.2017.07.070. Epub 2017 Aug 7.

Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.

Arch Roum Pathol Exp Microbiol. 1986 Jul-Dec;45(3-4):247-56.

Pathogenesis of Shigella infections.

Pathol Immunopathol Res. 1987;6(2):117-27. doi: 10.1159/000157053.

[Antibody against Shigella in bacillary dysentery patients and carries. 2. Studies of flexneri-dystery].

Kansenshogaku Zasshi. 1970 Nov;44(8):431-8. doi: 10.11150/kansenshogakuzasshi1970.44.431.

Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.

Arch Roum Pathol Exp Microbiol. 1984 Jul-Dec;43(3-4):195-230.

Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.

J Infect Dis. 1972 Jan;125(1):5-11. doi: 10.1093/infdis/125.1.5.

Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.

Res Immunol. 1996 Oct-Dec;147(8-9):595-602. doi: 10.1016/s0923-2494(97)85227-3.

引用本文的文献

Development and Characterization of a Polyvalent Polyclonal Antibody as a Common Capture Antibody for the Detection of Enterotoxigenic Escherichia coli in a Sandwich ELISA.

Curr Microbiol. 2025 Mar 7;82(4):177. doi: 10.1007/s00284-025-04154-9.

From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.

Vaccines (Basel). 2022 Apr 20;10(5):645. doi: 10.3390/vaccines10050645.

Shigella-Controlled Human Infection Models: Current and Future Perspectives.

Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248.

Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection.

Cell Host Microbe. 2021 Oct 13;29(10):1521-1530.e10. doi: 10.1016/j.chom.2021.08.010. Epub 2021 Sep 6.

NAIP-NLRC4-deficient mice are susceptible to shigellosis.

Elife. 2020 Oct 19;9:e59022. doi: 10.7554/eLife.59022.

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies.

Clin Infect Dis. 2019 Dec 9;69(Suppl 8):S580-S590. doi: 10.1093/cid/ciz892.

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview.

Clin Infect Dis. 2019 Dec 9;69(Suppl 8):S577-S579. doi: 10.1093/cid/ciz886.

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints.

Clin Infect Dis. 2019 Dec 9;69(Suppl 8):S591-S595. doi: 10.1093/cid/ciz891.

Mechanisms of bacillary dysentery: lessons learnt from infant rabbits.

Gut Microbes. 2020 May 3;11(3):597-602. doi: 10.1080/19490976.2019.1667726. Epub 2019 Oct 1.

The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: a consensus statement.

BMC Med. 2019 Aug 28;17(1):173. doi: 10.1186/s12916-019-1410-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验